AI is accelerating drug discovery by analyzing massive datasets and speeding up testing processes. Leading researchers from Georgia Tech and Vanderbilt University discussed this transformative technology at a recent webinar.
← News
Tech for Good Tech for Good Frontiers
AI is reengineering drug discovery by speeding up testing and scanning petabytes of data
Artificial Intelligence Technology
Faster Drug Discovery Primary benefit
Petabytes Data scale
Georgia Tech, Vanderbilt Expert institutions
Petabyte-Level Data scale
Accelerated Testing benefit
Drug Discovery application